Publikationen

2019

Oxygen Disrupts Human Fetal Lung Mesenchymal Cells. Implications for Bronchopulmonary Dysplasia.
Möbius MA, Freund D, Vadivel A, Koss S, McConaghy S, Ohls RK, Rüdiger M, Thébaud B
10.1165/rcmb.2018-0358OC 

Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System.
Marín Morales JM, Münch N, Peter K, Freund D, Oelschlägel U, Hölig K, Böhm T, Flach AC, Keßler J, Bonifacio E, Bornhäuser M, Fuchs A
10.3389/fimmu.2019.00038

2016

Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia.
Möbius MA, Rüdiger M
10.1186/s40348-016-0046-6

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome.
von Dalowski F, Kramer M, Wermke M, Wehner R, Röllig C, Alakel N, Stölzel F, Parmentier S, Sockel K, Krech M, Schmitz M, Platzbecker U, Schetelig J, Bornhäuser M, von Bonin M
10.1002/stem.2224

2015

Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.
Theil A, Tuve S, Oelschlägel U, Maiwald A, Döhler D, Oßmann D, Zenkel A, Wilhelm C, Middeke JM, Shayegi N, Trautmann-Grill K, von Bonin M, Platzbecker U, Ehninger G, Bonifacio E, Bornhäuser M
10.1016/j.jcyt.2014.11.005

2011

Differential effect of platelet-rich plasma and fetal calf serum on bone marrow-derived human mesenchymal stromal cells expanded in vitro.
Goedecke A, Wobus M, Krech M, Münch N, Richter K, Hölig K, Bornhäuser M
10.1002/term.359

2009

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium.
von Bonin M, Stölzel F, Goedecke A, Richter K, Wuschek N, Hölig K, Platzbecker U, Illmer T, Schaich M, Schetelig J, Kiani A, Ordemann R, Ehninger G, Schmitz M, Bornhäuser M
10.1038/bmt.2008.316